Alnylam Pharmaceuticals, Inc. ALNY
151.64 USD -4.97 (-3.17%)
At closeNov 10, 2026, 5:31 PM EST
151.64 0.00 0.00%
After hours · Nov 10, 5:31 PM ET
149.18 Day range 158.82
149.18 52-week range 479.79
- YTD
- -61.87%
- 1 year
- -65.67%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.71B | 2.25B | 1.83B | 1.04B | 844.29M | |
| 3.03B | 1.92B | 1.52B | 868.60M | 704.14M | |
| 501.58M | -176.88M | -282.18M | -785.07M | -708.65M | |
| 313.75M | -278.16M | -440.24M | -1.13B | -852.82M | |
| 2.33 | -2.18 | -3.52 | -9.30 | -7.20 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.66B | 966.43M | 812.69M | 866.39M | 819.98M | |
| 4.97B | 4.24B | 3.83B | 3.55B | 3.64B | |
| 4.18B | 4.17B | 4.05B | 3.70B | 3.06B | |
| 2.97B | 3.14B | 2.68B | 2.61B | 2.19B | |
| 789.18M | 67.09M | -220.64M | -158.22M | 588.20M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 524.08M | -8.31M | 104.16M | -541.27M | -641.69M | |
| 436.33M | -116.84M | -336.35M | 169.35M | -273.30M | |
| -305.19M | 294.16M | 172.13M | 425.75M | 1.25B | |
| -58.70M | -34.28M | -62.21M | -72.06M | -76.37M | |
| 690.15M | 153.77M | -53.67M | 46.40M | 323.11M |